08-24	Rznomics Joins Lilly Gateway Labs In San Diego	CI
06-21	Rznomics Inc.(KOSDAQ:A476830) added to S&P Global BMI Index	CI
06-15	Rznomics Presents Interim Clinical Data for Rz-001 in Recurrent Glioblastoma	CI
05-08	Rznomics Announces U.S. FDA Regenerative Medicine Advanced Therapy Designation Granted To RZ-001 For Hepatocellular Carcinoma	CI
04-20	Rznomics Reports Interim Clinical Data for Rz-001 in Hepatocellular Carcinoma	CI
03-17	Certain Common Stock of Rznomics Inc. are subject to a Lock-Up Agreement Ending on 18-MAR-2026.	CI
01-17	Certain Common Stock of Rznomics Inc. are subject to a Lock-Up Agreement Ending on 18-JAN-2026.	CI
12-18	Rznomics Inc. has completed an IPO in the amount of KRW 46.35 billion.	CI

Managers and Directors : Rznomics Inc.

Manager	Title	Age	Since
Seong-Wook Lee CEO	Chief Executive Officer	63	2017-08-28
Jong-Sun Rim DFI	Director of Finance/CFO	48	2025-10-15
Seung-Ryul Han CTO	Chief Tech/Sci/R&D Officer	45	-

Director	Title	Age	Since
Seong-Wook Lee CHM	Chairman	63	-
Seung-Ryul Han BRD	Director/Board Member	45	-
Sung-Woo Hong BRD	Director/Board Member	48	-

More insiders

Rznomics Inc is a Korea-based company principally engaged in the development of ribonucleic acid (RNA) editing and correction technologies. The Companyâ€™s main products include RNA editing enzyme-based gene therapies, self-circularized RNA structures, and RNA platform technologies. The Company sells its products in domestic and overseas markets.

Employees

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume
26-09-01	₩28,750.00	-4.49%	149,141
26-08-31	₩30,100.00	-3.99%	416,656
26-08-28	₩31,350.00	-0.79%	179,734
26-08-27	₩31,600.00	+0.32%	292,383
26-08-26	₩31,500.00	-1.41%	324,036

End-of-day quote Korea S.E.

More quotes

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

End-of-day quote Korea S.E. 2026-09-01			5-day change	1st Jan Change
28,750.00 ^KRW	-4.49%		-8.15%	-64.17%

1 day	-4.49%
1 week	-8.15%
Current month	-4.49%
1 month	+19.05%
3 months	-54.40%
6 months	-61.15%
Current year	-64.17%

1 week	28,600	34,900
1 month	23,400	39,200
Current year	19,990	122,625
1 year	19,990	122,625
3 years	19,990	122,625
5 years	19,990	122,625
10 years	19,990	122,625

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
RZNOMICS INC.	-4.49%	-8.15%	-	-	613M
WUXI APPTEC CO., LTD.	-0.25%	-0.92%	+49.47%	+89.45%	68.13B
ARGENX SE	+1.21%	+2.55%	+46.72%	+90.66%	63.6B
WUXI BIOLOGICS (CAYMAN) INC.	+1.31%	+1.81%	+49.04%	+12.07%	25.57B
INSMED INCORPORATED	-0.25%	-1.99%	-10.72%	+455.09%	26.6B
BIONTECH SE	+0.33%	-9.64%	+1.95%	-15.70%	25.52B
PHARMAESSENTIA CORPORATION	-6.09%	-11.19%	+224.80%	+351.08%	18.23B
GENMAB A/S	+1.18%	+1.66%	+35.20%	-18.67%	19.69B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-1.49%	-6.35%	+7.84%	+540.26%	15.16B
EXELIXIS, INC.	+4.12%	+4.29%	+52.03%	+154.09%	13.54B
Average	-0.44%	-4.33%	+50.70%	+184.26%	27.67B
Weighted average by Cap.	+0.14%	-2.88%	+47.00%	+145.57%

Rznomics Inc. Stock

Stocks

A476830

KR7476830005

Biotechnology & Medical Research

Chart: Rznomics Inc.

Latest news : Rznomics Inc.

Quotes and Performance

Price Extremes

Managers and Directors : Rznomics Inc.

Bio Therapeutic Drugs

Company Profile

Quotes